Genomed (WAR:GEN) Cyclically Adjusted Book per Share: zł8.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:GEN Genomed SA WAR:GEN
80 GF Score
Price zł29.80
GF Value zł36.09
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genomed Cyclically Adjusted Book per Share?

Genomed WAR:GEN +0.68% 80 Cyclically Adjusted Book per Share is zł8.00 as of Jun. 2026. GuruFocus rates WAR:GEN with a GF Score™ of 80/100 and a GF Value™ of zł36.09 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Genomed's adjusted book value per share for the three months ended in Jun. 2026 was zł9.375. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł8.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Genomed's average Cyclically Adjusted Book Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Genomed was 13.90% per year. The lowest was 9.70% per year. And the median was 11.80% per year.

As of today (2026-08-27), Genomed's current stock price is zł29.80. Genomed's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was zł8.00. Genomed's Cyclically Adjusted PB Ratio of today is 3.73.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genomed was 7.92. The lowest was 3.01. And the median was 4.65.


Genomed  (WAR:GEN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Genomed's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=29.80/8.00
=3.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Genomed was 7.92. The lowest was 3.01. And the median was 4.65.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Genomed Cyclically Adjusted Book per Share Related Terms


Genomed Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Genomed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomed Cyclically Adjusted Book per Share Chart

Genomed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.68 5.74 6.32 6.91 7.57

Genomed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.24 7.39 7.57 7.93 8.00

WAR:GEN vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Genomed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomed Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genomed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Genomed's Cyclically Adjusted PB Ratio falls into.


WAR:GEN
80GF Score
Genomed SA WAR:GEN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genomed's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=9.375/162.2800*162.2800
=9.375

Current CPI (Jun. 2026) = 162.2800.

Genomed Quarterly Data

Book Value per Share CPI Adj_Book
201609 3.310 99.064 5.422
201612 3.220 100.366 5.206
201703 3.432 101.018 5.513
201706 3.657 101.180 5.865
201709 4.045 101.343 6.477
201712 4.584 102.564 7.253
201803 5.058 102.564 8.003
201806 5.344 103.378 8.389
201809 5.344 103.378 8.389
201812 5.703 103.785 8.917
201903 5.575 104.274 8.676
201906 4.817 105.983 7.376
201909 4.942 105.983 7.567
201912 5.462 107.123 8.274
202003 5.361 109.076 7.976
202006 5.254 109.402 7.793
202009 5.272 109.320 7.826
202012 5.722 109.565 8.475
202103 5.481 112.658 7.895
202106 5.768 113.960 8.214
202109 5.954 115.588 8.359
202112 6.659 119.088 9.074
202203 6.787 125.031 8.809
202206 6.363 131.705 7.840
202209 6.525 135.531 7.813
202212 6.915 139.113 8.067
202303 6.805 145.950 7.566
202306 6.572 147.009 7.255
202309 6.622 146.113 7.355
202312 7.616 147.741 8.365
202403 7.151 149.044 7.786
202406 7.017 150.997 7.541
202409 7.286 153.439 7.706
202412 8.114 154.660 8.514
202503 8.294 157.021 8.572
202506 8.343 157.509 8.596
202509 9.423 158.000 9.678
202512 11.222 158.320 11.503
202603 10.650 163.070 10.598
202606 9.375 162.280 9.375

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of zł8.00 mean?
Genomed (WAR:GEN) has a Cyclically Adjusted Book per Share of zł8.00 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Genomed and its competitors.
Is Genomed's Cyclically Adjusted Book per Share too high?
Genomed's current Cyclically Adjusted Book per Share is zł8.00. Overall, Genomed has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomed's Cyclically Adjusted Book per Share compare to TMO and DHR?
Genomed's Cyclically Adjusted Book per Share of zł8.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Genomed and its competitors. Genomed's current Cyclically Adjusted Book per Share is zł8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomed stock overvalued right now?
Based on GuruFocus' analysis, Genomed (WAR:GEN) is currently considered Modestly Undervalued. The stock's GF Value™ is zł36.09, compared to a current price of zł29.80 — trading 17.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is zł8.00. Genomed's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Genomed (WAR:GEN), the current Cyclically Adjusted Book per Share is zł8.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomed (WAR:GEN) Overvalued in 2026?

Based on GuruFocus' analysis, Genomed stock appears to be undervalued. The current stock price of zł29.80 is trading 17.4% below its estimated GF Value™ of zł36.09. GuruFocus considers Genomed to be Modestly Undervalued.

Key valuation signals for WAR:GEN:

  • Cyclically Adjusted Book per Share: zł8.00
  • GF Value™: zł36.09 vs. price of zł29.80 (17.4% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the WAR:GEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genomed Business Description

Address Ulica Ponczowa 12, Warszawa, POL, 02-971
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
80GF Score

Get the complete analysis for WAR:GEN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł29.80
Price
zł36.09
GF Value